Percutaneous penetration enhancement: Physicochemical considerations and implications for prodrug design

Richard H. Guy; Jonathan Hadgraft

doi:10.1081/CRP-100108175

Percutaneous penetration enhancement: Physicochemical considerations and implications for prodrug design

Research output: Contribution to journal › Article › peer-review

2 Citations (SciVal)

Original language	English
Pages (from-to)	219-233
Number of pages	15
Journal	Clinical Research and Regulatory Affairs
Volume	18
Issue number	3
DOIs	https://doi.org/10.1081/CRP-100108175
Publication status	Published - 1 Jan 2001

ASJC Scopus subject areas

Pharmacology
Pharmaceutical Science
Pharmacology (medical)

Access to Document

10.1081/CRP-100108175

Cite this

@article{74044edd9f274cd1b637d651cdeb123a,

title = "Percutaneous penetration enhancement: Physicochemical considerations and implications for prodrug design",

author = "Guy, {Richard H.} and Jonathan Hadgraft",

year = "2001",

month = jan,

day = "1",

doi = "10.1081/CRP-100108175",

language = "English",

volume = "18",

pages = "219--233",

journal = "Clinical Research and Regulatory Affairs",

issn = "1060-1333",

publisher = "Taylor and Francis",

number = "3",

}

TY - JOUR

T1 - Percutaneous penetration enhancement

T2 - Physicochemical considerations and implications for prodrug design

AU - Guy, Richard H.

AU - Hadgraft, Jonathan

PY - 2001/1/1

Y1 - 2001/1/1

UR - http://www.scopus.com/inward/record.url?scp=84862270605&partnerID=8YFLogxK

U2 - 10.1081/CRP-100108175

DO - 10.1081/CRP-100108175

M3 - Article

AN - SCOPUS:84862270605

SN - 1060-1333

VL - 18

SP - 219

EP - 233

JO - Clinical Research and Regulatory Affairs

JF - Clinical Research and Regulatory Affairs

IS - 3

ER -

Percutaneous penetration enhancement: Physicochemical considerations and implications for prodrug design

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this